Tyrosine phosphorylation of proteins, controlled by tyrosine kinases and protein tyrosine phosphatases, plays a key role in cellular growth and differentiating. A wide variety of hormones, growth factors, and cytokines modulate cellular tyrosine phosphorylation to transmit signals across the plasma membrane to the nucleus. Recent studies suggest that reactive oxygen species (ROS) also induce cellular protein tyrosine phosphorylation through receptor or nonreceptor tyrosine kinases. To determine whether protein tyrosine phosphorylation by ROS regulates endothelial cell (EC) metabolism and function, we exposed vascular ECs to H202 or H202 plus vanadate. This resulted in a time-and dose-dependent increase in protein tyrosine phosphorylation of several proteins (Mr 21-200 kDa), as determined by immunoprecipitation and Western blot analysis with antiphosphotyrosine antibody. Immunoprecipitation with specific antibodies identified increased tyrosine phosphorylation of mitogen-activated protein kinases (42-44 kDa), paxillin (68 kDa), and FAK (125 kDa) by ROS. An immediate signaling response to increased protein tyrosine phosphorylation by ROS was activation of phospholipases such as A2, C, and D. Suramin pretreatment inhibited ROS stimulation of phospholipase D (PLD), suggesting a role for growth factor receptors in this activation. Further, PLD activation by ROS was attenuated by Nacetylcysteine, indicating that intracellular thiol status is critical to ROS-mediated signal transduction. These results provide evidence that ROS modulate EC signal transduction via a protein tyrosine phosphorylation-dependent mechanism.
Introduction
Reactive oxygen species (ROS), generated at implicated in cell damage through oxidative relatively high levels by activated leukocytes, modification of cellular macromolecules or by inhalation of environmental toxins (1, 2) . Several studies have implicated ROS such as asbestos, silica, and ozone, have been in the pathophysiology of vascular disorders Abbreviations used: AA, arachidonic acid; AM, acetoxymethylester; BPAEC, bovine pulmonary artery endothelial cell; BCA, bicinchoninic acid; BRK, bradykinin; DAG, diacylglycerol; DMEM, Dulbecco's modified Eagle's medium; DPV, diperoxovanadate; EC, endothelial cell; ECL, enhanced chemiluminescence; FAK, focal adhesion kinase; IB, immunoblotting; IP, immunoprecipitation; 1P3, inositol 1,4,5-trisphosphate; PA, phosphatidic acid; PBS, phosphate-buffered saline; PBt, phosphatidylbutanol; PKC, protein kinase C; PLA2, phospholipase A2; PLC, phospholipase C; PLD, phospholipase D; PMSF, phenylmethylsulfonyl fluoride; PTP, protein tyrosine phosphatase; PY, phosphotyrosine; RIPA, radioimmunprecipitation assay; ROS, reactive oxygen species; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; TLC, thin-layer chromatography; TPA, 12-O-tetradecanoylphorbol-13-acetate; 6-keto PGFi,, 6 -keto prostaglandin F1,,, including atherosclerosis, pulmonary hypertension, vasculitis, and ischemiareperfusion (3) (4) (5) (6) . However, the mechanisms of ROS-induced vascular disorders are poorly defined. Recent studies suggest that the effects of ROS in the vascular endothelium are not entirely mediated through damage to cellular components but may involve modulation of signal transduction pathways (7, 8) . This concept is supported by a number of recent observations that ROS stimulate protein kinase C, tyrosine kinases, mitogen-activated protein (MAP) kinases, Ca2+ signaling pathways, phospholipases, and regulate transcription factors. Furthermore, some of the toxic effects mediated by environmental toxins and ROS are blocked by free radical scavengers and antioxidants (7) .
Tyrosine phosphorylation of proteins, a balance between tyrosine kinases and protein tyrosine phosphatases (PTPs), is modulated by a variety of hormones, growth factors, and cytokines (9, 10) . Recent reports indicate that ROS induce cellular protein tyrosine phosphorylation through receptor and nonreceptor tyrosine kinases (11, 12) . H202 alone or in combination with vanadate, which generates peroxovanadium compounds, modulates intracellular calcium (13) , and activates phospholipases (14) (15) (16) and mitogenactivated protein kinases (17) through modulation of protein kinase/phosphatases. However, the physiologic significance of protein tyrosine phosphorylation by ROS in endothelial cell (EC) metabolism and function is not well understood. This study was undertaken to examine the ability of ROS to modulate EC function through protein tyrosine phosphorylationdependent signaling pathways. Our As ROS are potent inhibitors of PTPs (13, 26) , it was necessary to determine the effect of H202 and H202 plus vanadate on tyrosine kinase and phosphatase activities in ECs. As shown in Figure 1 , H202 treatment of BPAECs increased tyrosine kinase activity without altering the PTP activity. However, 10 pM vanadate inhibited the PTP activity without altering the tyrosine kinase activity. A combination of vanadate plus H202 was a potent inhibitor of PTP (> 80% inhibition) and activator of tyrosine kinase (3-fold over control). These data suggest that modulation of tyrosine kinase and PTP activities in ECs is dependent on the nature of ROS used.
ROS Increases Tyrosine Phosphorylation ofProteins in ECs
Modulation of tyrosine kinases/PTPs by ROS may increase protein tyrosine phosphorylation of ECs in a manner similar to that in other cell types (27) . Treatment of BPAECs with varying concentrations of H202 resulted in a dose-dependent increase in tyrosine phosphorylation of several proteins, as determined by immunoblotting with antiphosphotyrosine antibody (Figure 2 accumulation as well as protein tyrosine phosphorylation ( with 50% inhibition at 100 pM suramin (Table 6 ). These results suggest that growth factor receptors may be involved in ROS-mediation PLD activation.
Effct ofAntioxidants on ROS-Mediated PLD Activation
As proteins and lipids are likely targets through which ROS can modulate cell signaling, we investigated the effect of antioxidants on DPV-induced PLD activation. Enhancing the EC redox state by pretreatment with N-acetylcysteine abolished the ability of DPV to activate PLD activity (Table 7) . These results suggest that modulation of sulfhydryl reactivity by DPV is blocked by N-acetylcysteine.
Discussion
In this study, the effects of ROS on activation of PLA2, PLC, and PLD and protein tyrosine phosphorylation in ECs were examined. stimulates P13 kinase (28) , and enhances protein tyrosine phosphorylation (29) . The mechanism(s) involved in tyrosine kinase-mediated activation of PLA2, PLC, and PLD is unclear. There is increasing evidence for the involvement of protein tyrosine phosphorylation in growth factor-, oxidant-, and IgE-mediated PLD activities. However, the nature of tyrosine phosphorylated proteins involved in PLD activation has not been identified. Earlier studies by Vepa et al. (24) indicate that caveolin and FAK (125 kDa) are targets for H202 in ECs. In this study, we have identified ERK-1 and ERK-2 and focal adhesion proteins (FAK and paxillin) as potential targets for ROS-induced tyrosine phosphorylation. Exogenous addition of oxidants induced tyrosine phosphorylation of ERK-1 and ERK-2, and this activation was mediated in Table 7 . Effect of N-acetylcysteine on ROS-and TPA-induced PLD activation.
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